Package Insert: Information for the User
Read this package insert carefully before starting to take this medication, as it contains important information for you.
Sertralina Viatris contains sertraline as the active ingredient. Sertraline belongs to a group of medications called selective serotonin reuptake inhibitors (SSRIs); these medications are used to treat depression and/or anxiety disorders.
Sertraline may be used to treat:
Depression is a clinical disease with symptoms such as feelings of sadness, inability to sleep well or to enjoy life as one used to.
OCD and anxiety disorders are anxiety-related diseases, with symptoms such as being constantly preoccupied with repeated ideas (obsessions) that lead to repetitive rituals (compulsions).
PTSD is a disorder that may occur after a very emotionally traumatic experience, and has some symptoms similar to depression and anxiety. Social anxiety disorder (social phobia) is an anxiety-related disease. It is characterized by intense anxiety or anguish in social situations (for example: speaking to strangers, speaking in public, eating or drinking in front of others, or worrying about behaving in a humiliating manner).
Your doctor has considered this medication suitable for treating your condition.
If you are unsure why you have been prescribed sertraline, you should consult your doctor.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Sertralina Viatris.
Medications are not always suitable for everyone. Before starting treatment with sertraline, tell your doctor if you have or have had any of the following conditions:
Restlessness/Acatisia
The use of sertraline has been associated with acatisia with unpleasant restlessness and a need to move, often accompanied by an inability to sit or stand still (acatisia). This occurs more often during the first weeks of treatment. Increasing the dose in patients who develop these symptoms may be harmful, so you should contact your doctor.
Withdrawal symptoms
Side effects related to stopping treatment (withdrawal symptoms) are common, particularly if treatment is stopped abruptly (see section 3, If you stop taking Sertralina Viatris and section 4, Possible side effects). The risk of withdrawal symptoms depends on the duration of treatment, the dose, and the rate at which the dose is reduced. Generally, these symptoms are mild or moderate. However, in some patients, they can be severe. These symptoms usually occur during the first few days after stopping treatment. In general, these symptoms usually resolve on their own and usually resolve within two weeks. In some patients, they may last longer (2-3 months or more). It is recommended that, when stopping treatment with sertraline, the dose be gradually reduced over a period of several weeks or even months, and you should always agree with your doctor on the best way to stop treatment.
Thoughts of suicide and worsening of depression or anxiety
If you are depressed and/or have anxiety disorders, you may have thoughts of harming yourself or committing suicide. This may increase at the beginning of treatment with antidepressants, as all these medications take time to take effect, which is usually two weeks, but sometimes it may be longer.
This is more likely to happen
If you have thoughts of harming yourself or committing suicide at any time, contact your doctor or go to the hospital immediately.
It may be helpful to explain to a close family member or friend that you are depressed or have anxiety disorders, and ask them to read this leaflet. You can also ask them to tell you if they think your depression or anxiety is getting worse, or if they are concerned about changes in your behavior.
Sexual dysfunction
Medications such as sertraline (also known as ISRS/IRSN) may cause symptoms of sexual dysfunction (see section 4). In some cases, these symptoms have continued after stopping treatment.
Children and adolescents
Other medications and Sertralina Viatris
Some medications may affect how sertraline works, or sertraline itself may reduce the effectiveness of other medications that you are taking at the same time.
The use of sertraline with the following medications may cause severe side effects
Inform your doctor if you are taking the following medications
If you are pregnant or breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before using this medication.
The safety of sertraline in pregnant women has not been fully established. If you are pregnant, sertraline will only be administered to you if your doctor considers that the benefits for you outweigh any possible risk to the developing fetus.
If you take sertraline in the final stages of pregnancy, there may be an increased risk of heavy vaginal bleeding shortly after delivery, especially if you have a history of bleeding disorders. Your doctor or midwife should know that you are taking sertraline so that they can advise you. When taking sertraline during pregnancy, especially in the last three months of pregnancy, medications like sertraline may increase the risk of a serious condition in newborns called persistent pulmonary hypertension of the newborn (PPHN), which makes the baby breathe faster and appear blue. These symptoms usually start within the first 24 hours after birth. If this happens to your baby, contact your midwife and/or doctor immediately.
Your newborn baby may have other conditions, which usually manifest within the first 24 hours after birth. The symptoms include:
If your baby has any of these symptoms at birth, or you are concerned about your baby's health, consult your doctor or midwife for advice.
There is evidence that sertraline passes into breast milk. Therefore, sertraline can only be used in women who are breastfeeding if your doctor considers that the benefits outweigh any possible risk to the baby.
Studies in animals have shown that some medications, such as sertraline, may reduce the quality of sperm. Theoretically, this could affect fertility, but it has not yet been determined in humans.
Medications like sertraline can affect your ability to drive or operate machinery. Therefore, do not drive or operate heavy machinery until you know how this medication affects your ability to do so.
Sertralina Viatris contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; this is, essentially "sodium-free".
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
You may notice that this medication has an unusual smell and/or taste. This is normal and can be minimized by taking it with a glass of water, immediately after bringing it to your mouth.
Adults:
Depression and Obsessive-Compulsive Disorder:
The commonly effective dose for depression and OCD is 50 mg per day. The daily dose can be increased by 50 mg, at intervals of at least one week, and thus for several weeks. The maximum recommended dose is 200 mg per day.
Anxiety Disorder, Social Anxiety Disorder, and Post-Traumatic Stress Disorder:
For anxiety disorder, social anxiety disorder, and post-traumatic stress disorder, treatment should start with a dose of 25 mg per day, and increased to 50 mg per day after one week.
The daily dose can be increased in intervals of 50 mg over a period of several weeks. The maximum recommended dose is 200 mg per day.
Use in children and adolescents:
Sertraline should only be used to treat children and adolescents from 6 to 17 years old who present with OCD.
Obsessive-Compulsive Disorder:
Children from 6 to 12 years:The recommended starting dose is 25 mg per day. After one week, your doctor may increase the dose to 50 mg per day. The maximum dose is 200 mg per day.
Adolescents from 13 to 17 years:The recommended starting dose is 50 mg per day. The maximum dose is 200 mg per day.
If you have liver or kidney problems, inform your doctor and follow the instructions they give you..
Administration form:
Sertraline Viatris tablets can be taken with or without food.
Take your medication once a day, either in the morning or at night.
Your doctor will indicate the duration of treatment with this medication. The duration will depend on the nature of your illness and your response to treatment. It will take several weeks for your symptoms to start improving. Treatment of depression should continue for 6 months after improvement.
If you take more Sertraline Viatris than you should
If you have taken more sertraline than you should, contact your doctor or pharmacist or go to the nearest hospital.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service (Tel: 91 562 04 20) indicating the medication and the amount ingested.
The symptoms of overdose may include drowsiness, nausea, and vomiting, rapid heart rate, tremors, agitation, dizziness, and in rare cases, unconsciousness.
If you forgot to take Sertraline Viatris
Do not take a double dose to compensate for the missed doses. If you forget to take a dose, do not take it when you remember. Take the next dose when it is due.
If you interrupt treatment with Sertraline Viatris
Do not stop treatment with sertraline unless your doctor tells you to. Your doctor will want to gradually reduce the dose of sertraline over several weeks before stopping it completely. If you stop treatment abruptly, you may experience adverse effects such as dizziness, numbness, sleep disturbances, agitation, or anxiety, headaches, nausea, vomiting, and tremors. If you experience any of these adverse effects, or any other during the interruption of your treatment with sertraline, please inform your doctor.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, sertraline may cause side effects, although not everyone will experience them.
The most common side effect is nausea. Side effects depend on the dose and often disappear or decrease as treatment continues.
Inform your doctor immediately
If you experience any of the following symptoms after taking this medication, as these symptoms may be serious.
The following side effects were observed in clinical trials in adults and after marketing.
Very common side effects(may affect more than 1 in 10 patients):
Insomnia, dizziness, drowsiness, headache, diarrhea, feeling unwell, dry mouth, ejaculation problems, and fatigue.
Common side effects(may affect up to 1 in 10 patients):
Uncommon side effects(may affect up to 1 in 100 patients):
-Gastroenteritis, ear infection.
-Tumor.
-Hypersensitivity, seasonal allergy.
-Low levels of thyroid hormones.
-Suicidal thoughts, suicidal behavior*, psychotic disorders, abnormal thoughts, lack of care, hallucinations, aggression, excessive happiness, paranoia.
-Amnesia, decreased sensitivity, involuntary muscle contractions, fainting, continuous movements, migraine, convulsions, dizziness when standing up, abnormal coordination, speech disorders.
-Dilated pupils.
-Ear pain.
-Accelerated pulse, heart problems.
-Bleeding problems (such as stomach bleeding)*, high blood pressure, hot flashes, blood in urine.
-Shortness of breath, nasal bleeding, possible noisy breathing.
-Black stools, dental disorders, esophageal inflammation, tongue problems, hemorrhoids, excessive salivation, difficulty swallowing, belching, tongue disorders.
-Swollen eyes, urticaria, hair loss, itching, purple spots on the skin, skin disorders with blisters, dry skin, facial swelling, cold sweat.
-Arthritis, muscle spasms, muscle cramps*, muscle weakness.
-Increased frequency of urination, urinary disorders, urinary retention, urinary incontinence, increased urine volume, need to urinate at night.
-Sexual dysfunction, excessive vaginal bleeding, vaginal bleeding, female sexual dysfunction.
-Swollen legs, chills, difficulty walking, thirst.
-Altered liver enzymes, weight loss.
-There have been reports of thoughtsandbehavioral changes during treatment with sertraline or shortly after discontinuation (see section 2).
Rare side effects(may affect up to 1 in 1,000 patients):
-Diverticulitis, swollen lymph nodes, decreased platelets*, decreased white blood cell count*.
-Severe allergic reaction.
-Endocrine problems*.
-High cholesterol, difficulty controlling blood sugar levels (diabetes), low blood sugar, high blood sugar*, low sodium levels in the blood*.
-Physical symptoms due to stress or emotions, abnormal nightmares*, medication dependence, sleepwalking, premature ejaculation.
-Coma, abnormal movements, difficulty moving, increased sensitivity, sudden severe headache (which may be a sign of a serious condition known as reversible cerebral vasoconstriction syndrome (RCVS))*, sensory disturbances.
-Seeing spots in front of the eyes, glaucoma, double vision, photophobia (light sensitivity), eye bleeding, irregular pupils*, visual disturbances*, eye problems.
-Appearance of spots in the visual field, glaucoma, double vision, eye damage from light, blood in the eye, unequal pupil size*, abnormal vision*, eye problems.
-Heart attack, dizziness, fainting or chest discomfort that may be signs of changes in electrical activity (seen on the electrocardiogram) or abnormal heart rhythm*, decreased heart rate.
-Problems with circulation in the arms and legs.
-Accelerated breathing, progressive scarring of lung tissue (interstitial lung disease)*, throat spasms, difficulty speaking, slower breathing, hiccups.
-Mouth ulcers, pancreatitis*, blood in stools, tongue ulcers, mouth sores.
-Liver function problems, severe liver function disorders*, yellow skin and eyes (jaundice)*.
-Sun sensitivity*, skin swelling*, abnormal hair texture, abnormal skin odor, capillary eruption.
-Muscle tissue rupture*, bone disorders.
-Interrupted urination, decreased urine volume.
-Milk secretion, vaginal dryness, genital secretion, penile and preputial pain and redness, breast enlargement*, prolonged erection.
-Hernia, decreased tolerance to the medication.
-High cholesterol levels, abnormal analytical tests*, abnormal semen, coagulation problems*.
-Relaxation of blood vessel procedure.
Unknown frequency(cannot be estimated from available data):
-Trigeminal nerve block,
-Nocturnal urinary incontinence*.
-Partial loss of vision.
-Colitis inflammation (causing diarrhea).
-Abundant vaginal bleeding shortly after delivery (postpartum hemorrhage), see “Pregnancy, lactation, and fertility” in section 2 for more information.
*Side effects reported after marketing
Other side effects in children and adolescents
In clinical trials in children and adolescents, side effects were generally similar to those reported in adults (see above). The most common side effects in children and adolescents were headache, insomnia, diarrhea, and nausea.
Symptoms that may appear when treatment is discontinued
If you discontinue treatment with this medication abruptly, you may experience side effects such as dizziness, numbness, sleep disturbances, agitation or anxiety, headaches, nausea, vomiting, and tremors (see section 3. If you discontinue treatment with Sertralina Viatris).
There has been an increased risk of bone fractures in patients taking this type of medication.
Reporting of side effects:
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Vigilance of Medicinal Products for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children
Do not use this medication after the expiration date that appears on the packaging, after CAD or EXP. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medications should not be disposed of through drains or in the trash.Deposit the packaging and medications you no longer need at your local SIGRE collection pointat your usual pharmacy. If in doubt, please ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Sertralina Viatris
Coating: hypromellose (E-464), titanium dioxide (E-171), polydextrose (E-1200), triacetin (E-1518) and macrogol.
Appearance of the product and content of the packaging
Sertralina Viatris 100 mg is presented in coated tablets with a white color, scored on one side, with the inscription “ST” and “100” on each side of the score and with the letter “G” on the back.
Sertralina Viatris is presented in packaging with blisters of 30 and 500 (clinical packaging) tablets and pre-cut single-dose blisters of 30x1 tablets.
Only some packaging sizes may be commercially available.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder:
Viatris Pharmaceuticals, S.L.U.
C/ General Aranaz, 86
28027 - Madrid
Spain
Responsible manufacturer:
McDermott Laboratories Limited trading as Gerard Laboratories
35/36 Baldoyle Industrial Estate
Grange Road, Dublin 13
Ireland
or
Mylan Hungary Kft
Mylan utca, 1
H-2900 Komárom
Hungary
Last review date of thisleaflet:December 2022
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)https://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.